| Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease MM Carrasquillo, F Zou, VS Pankratz, SL Wilcox, L Ma, LP Walker, ... Nature genetics 41 (2), 192-198, 2009 | 377 | 2009 |
| Fine mapping of the α-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees N Ertekin-Taner, J Ronald, H Asahara, L Younkin, M Hella, S Jain, ... Human molecular genetics 12 (23), 3133-3143, 2003 | 92 | 2003 |
| Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease MM Carrasquillo, O Belbin, F Zou, M Allen, N Ertekin-Taner, M Ansari, ... PloS one 5 (1), e8764, 2010 | 70 | 2010 |
| Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer’s disease F Zou, RK Gopalraj, J Lok, H Zhu, IF Ling, JF Simpson, HM Tucker, ... Human molecular genetics 17 (7), 929-935, 2008 | 70 | 2008 |
| Mindfulness and climate change action: A feasibility study M Grabow, T Bryan, MM Checovich, AK Converse, C Middlecamp, ... Sustainability 10 (5), 1508, 2018 | 41 | 2018 |
| Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease F Zou, MM Carrasquillo, VS Pankratz, O Belbin, K Morgan, M Allen, ... Neurology 74 (6), 480-486, 2010 | 40 | 2010 |
| A genome-wide study of de novo deletions identifies a candidate locus for non-syndromic isolated cleft lip/palate risk SG Younkin, RB Scharpf, H Schwender, MM Parker, AF Scott, ... BMC genetics 15, 1-9, 2014 | 35 | 2014 |
| Inferring rare disease risk variants based on exact probabilities of sharing by multiple affected relatives A Bureau, SG Younkin, MM Parker, JE Bailey-Wilson, ML Marazita, ... Bioinformatics 30 (15), 2189-2196, 2014 | 33 | 2014 |
| Detecting Disease Variants in Case‐Parent Trio Studies Using the Bioconductor Software Package trio H Schwender, Q Li, C Neumann, MA Taub, SG Younkin, P Berger, ... Genetic epidemiology 38 (6), 516-522, 2014 | 26 | 2014 |
| LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer’s disease (LOAD) S Lincoln, M Allen, CL Cox, LP Walker, K Malphrus, Y Qiu, T Nguyen, ... PloS one 8 (6), e64164, 2013 | 19 | 2013 |
| A genome‐wide study of inherited deletions identified two regions associated with nonsyndromic isolated oral clefts SG Younkin, RB Scharpf, H Schwender, MM Parker, AF Scott, ... Birth Defects Research Part A: Clinical and Molecular Teratology 103 (4 …, 2015 | 18 | 2015 |
| Fast detection of de novo copy number variants from SNP arrays for case-parent trios RB Scharpf, TH Beaty, H Schwender, SG Younkin, AF Scott, I Ruczinski BMC bioinformatics 13, 1-14, 2012 | 16 | 2012 |
| The Health-Oriented Transportation Model: Estimating the health benefits of active transportation SG Younkin, HC Fremont, JA Patz Journal of Transport & Health 22, 101103, 2021 | 12 | 2021 |
| Systematic evaluation of the impact of ChIP-seq read designs on genome coverage, peak identification, and allele-specific binding detection Q Zhang, X Zeng, S Younkin, T Kawli, MP Snyder, S Keleş BMC bioinformatics 17, 1-16, 2016 | 11 | 2016 |
| A tool for assessing the climate change mitigation and health impacts of environmental policies: the Cities Rapid Assessment Framework for Transformation (CRAFT) P Symonds, J Milner, N Mohajeri, J Aplin, J Hale, SJ Lloyd, H Fremont, ... Wellcome Open Research 5, 269, 2021 | 10 | 2021 |
| Analytic power and sample size calculation for the genotypic transmission/disequilibrium test in case‐parent trio studies C Neumann, MA Taub, SG Younkin, TH Beaty, I Ruczinski, H Schwender Biometrical Journal 56 (6), 1076-1092, 2014 | 10 | 2014 |
| On multi-marker tests for association in case-control studies MA Taub, HR Schwender, SG Younkin, TA Louis, I Ruczinski Frontiers in genetics 4, 252, 2013 | 7 | 2013 |
| The influence of socioeconomic characteristics on active travel in US metropolitan areas and the contribution to health inequity S Younkin, H Fremont, J Bratburd, D De Los Santos, J Patz Wellcome Open Research 8, 266, 2024 | 2 | 2024 |
| An new implementation of the integrated transport and health impacts model for the United States J Vargo, S Younkin, J Patz Journal of Transport & Health 5, S73-S74, 2017 | 2 | 2017 |
| Urokinase plasminogen activator haplotypes are significally associated with A beta 42 and late-onset Alzheimer's disease N Ertekin-Taner, J Ronald, S Younkin, L Younkin, M Hella, S Jain, ... Neurobiology of Aging 23 (1), S314-S314, 2002 | 2 | 2002 |
